Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIn the UK, Ozempic and Wegovy both contain semaglutide, but they are licensed for different conditions, which shapes how their costs are structured. Ozempic is licensed for type 2 diabetes and is available on NHS prescription for eligible patients; Wegovy is the weight-management version, available privately and through specialist NHS services. So when people ask whether Ozempic or Wegovy is cheaper, the honest answer is that comparing them directly is a little like comparing the price of a GP appointment to a private clinic visit — the right route depends entirely on your circumstances, and a prescriber decides which, if either, you can access. For most people seeking weight-loss treatment privately in the UK, Wegovy is the medicine that is actually licensed for that purpose, and its private cost is what matters in practice.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Ozempic and Wegovy are both semaglutide, but they hold separate UK marketing authorisations for separate conditions. The NHS medicines page for semaglutide makes the distinction clear: Ozempic is authorised for type 2 diabetes, and Wegovy is authorised for weight management. That licensing difference is not a technicality, it determines who can legally be prescribed each medicine and through which clinical pathway.
Ozempic is available on an NHS prescription for people with type 2 diabetes who meet prescribing criteria, which means many patients pay only the standard prescription charge or nothing at all. Wegovy is not routinely available on the NHS in the same way: NICE's appraisal of Wegovy (TA875) recommends it only within specialist weight management services and for a maximum of two years, with strict BMI and comorbidity thresholds. For the majority of people pursuing private weight-loss treatment, Wegovy is what they are actually looking for, and its private price is the relevant figure.
Prescribing Ozempic off-label for weight loss is a separate clinical decision that lies entirely with a prescriber; it is not something a regulated UK pharmacy offers as a standard route, and nume does not dispense Ozempic. If you are wondering whether Ozempic is cheaper than Wegovy and whether that makes it a practical alternative, the answer depends on factors that go well beyond the list price alone. The comparison most readers need is not Ozempic versus Wegovy on price, it is what a legitimate, supervised Wegovy prescription actually costs and what that price includes.
Private Wegovy pricing varies across providers and changes as doses increase through the titration schedule. After Eli Lilly's widely reported UK list-price revision in September 2025 reshaped the market, our page covering the Ozempic and Wegovy price cuts explains how that revision played out and what it meant for private costs, with typical private monthly costs for injectable weight-loss medicines broadly ranging from around £149 to £375 depending on dose and provider, figures that are reported across the industry, hedged, and subject to change. You can find a fuller breakdown on our Wegovy price page.
What those headline figures do not always tell you is what is actually included. Some providers charge separately for the consultation, the prescription, delivery, and ongoing clinical support. Others bundle some of these and not others. The result is that two providers quoting similar monthly figures may be offering very different levels of care. Seeing a low number and assuming it reflects the total cost of a safely supervised treatment course is a reasonable mistake, and an expensive one to make once you factor in the extras.
For context on how finding cheaper Wegovy options compares in practice, the key variable is rarely the headline pen price. It is whether clinical oversight, dose reviews, and aftercare are genuinely included or quietly billed later.
A legitimate private weight-loss prescription in the UK involves more than the medicine itself. The legal route to Wegovy requires a clinical assessment by a qualified prescriber, not a checkbox form reviewed by software. At nume, a named prescriber reads every consultation the same day. Photo-ID and live weight verification happen before any medicine is approved. GP notification is carried out in line with GPhC guidance. None of that is optional.
Delivery matters too. A pen that needs refrigeration (kept in the fridge door at home between doses) cannot be shipped in an untracked, uninsured envelope. At nume, every order is dispatched in temperature-appropriate packaging via DPD on a tracked, next-working-day service, in plain unbranded packaging, free of charge.
We are not the cheapest option on the market, and we have not tried to be. What a single price at nume covers: the consultation, the prescription, the treatment, delivery, and seven-day aftercare. No subscription, no automatic renewal, no hidden fees. Current treatment pricing is listed on our treatment page. Details of how the service works are on the about us page.
Wegovy and Mounjaro are Prescription-Only Medicines. The MHRA has warned publicly about counterfeit weight-loss pens sold online, fake pens have contained insulin, and enforcement operations through 2025 seized roughly 20 million doses of illegally traded weight-loss medicines worth around £45 million. The sellers offering the lowest prices are often the ones operating outside the licensed supply chain.
Red flags to recognise: a seller offering these medicines without asking for a prescription, prices well below the typical private market range, and discount codes promoted through social media. None of these are normal features of a GPhC-registered pharmacy. You can verify any online pharmacy on the GPhC register, nume's premises registration number is 9012878.
The better question is not which provider charges the least, but which one will keep you safe throughout treatment. A prescriber who reviews your case before every repeat order, who is reachable when something changes, and who sources medicine through the authorised UK supply chain is worth more than a small saving on the headline number. Our page comparing Ozempic vs Wegovy cost goes into more detail on why the active ingredient and the dose it is delivered in both shape what you end up paying, and understanding how much semaglutide is in Ozempic helps clarify why the two medicines sit at different price points even when they share the same active ingredient. If you want to explore what licensed weight-loss treatment through a regulated pharmacy looks like in practice, our weight-loss treatment overview is a good starting point, and you can read more about the clinical team behind nume on the clinical team page.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.